CRP and urinary bladder cancer: In a prospective study of 67 patients with inoperable bladder cancer, CRP was measured one day prior to initiation of chemotherapy (gemcitabine and cisplatin); elevated CRP was associated with both shorter PFS and shorter OS (20).